Reproductive Endocrinology and Infertility (REI) is one of three subspecialty fellowships for advanced training after completion of a residency in Obstetrics and Gynecology. Formal certification for this training in Reproductive Medicine is under the aegis of the Division of Reproductive Endocrinology and Infertility of the American Board of Obstetrics and Gynecology, Inc. This Board awards certificates of special competence for the practice of Reproductive Endocrinology and Infertility to individuals after completion of an accredited training program and subsequent passing of a written and finally an oral examination. The Society for Reproductive Endocrinology and Infertility (SREI), the national Society of Board Certified REIs, has as a major mission the support of programs involved in the selection, clinical and research training and networking of fellows. It is within this framework that the present competing renewal application is submitted. Research is a central feature of fellowship programs, which are academically rigorous and require a major commitment to research. This is the only formalized time during the training of Obstetrician/Gynecologists that such a rigorous commitment to an academic research exercise is required. More importantly, this is the only time when physicians in training have the opportunity to develop a lasting interest (and hopefully a passion) for research. This is the sole window through which the pipeline of academic reproductive medicine specialists can be kept open. During the past decade, financial constraints due to decreased reimbursement for clinical work have prompted the discontinuation of many (29%) fellowship programs in REI and a reduction of total fellowship positions (by 50%) in the continuing active programs. This is occurring at a time when there is an increase in the available academic positions and at a time of unprecedented advances in the research aspects of the field. The objective of the present proposal is to seek continued funding for a required 2 year training period in research for three fellows per year who are involved in meritorious research during their respective Board-approved fellowship training. It is anticipated that such support will continue to contribute to the early development of physician scientists and clinical investigators in the field of Reproductive Medicine and will better prepare fellows to enter the pipeline of NIH funded positions in the Reproductive Scientists Development Program (RSDP) and the Women's Reproductive Health Research Career Development initiatives (WRHR and BIRCWH). The first six graduates (through June 2006) of this novel Program have all entered academic positions, one as an RSDP scholar, two as WRHR and BIRCWH scholars, one as a Harold Amos scholar of the Robert Wood Johnson Foundation. Four are women and three are under represented minorities.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Institutional National Research Service Award (T32)
Project #
5T32HD040135-10
Application #
8071634
Study Section
Pediatrics Subcommittee (CHHD)
Program Officer
Taymans, Susan
Project Start
2001-07-01
Project End
2012-06-10
Budget Start
2011-05-01
Budget End
2012-06-10
Support Year
10
Fiscal Year
2011
Total Cost
$264,728
Indirect Cost
Name
University of Pennsylvania
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Sullivan-Pyke, Chantae S; Carlson, Claire A; Prewitt, Maureen et al. (2018) Ovarian tissue cryopreservation (OTC) in prepubertal girls and young women: an analysis of parents' and patients' decision-making. J Assist Reprod Genet 35:593-600
Grindler, N M; Allshouse, A A; Jungheim, E et al. (2018) OBGYN screening for environmental exposures: A call for action. PLoS One 13:e0195375
Grindler, N M; Vanderlinden, L; Karthikraj, R et al. (2018) Exposure to Phthalate, an Endocrine Disrupting Chemical, Alters the First Trimester Placental Methylome and Transcriptome in Women. Sci Rep 8:6086
Sullivan-Pyke, Chantae; Haisenleder, Daniel J; Senapati, Suneeta et al. (2018) Kisspeptin as a new serum biomarker to discriminate miscarriage from viable intrauterine pregnancy. Fertil Steril 109:137-141.e2
Sullivan-Pyke, Chantae; Dokras, Anuja (2018) Preimplantation Genetic Screening and Preimplantation Genetic Diagnosis. Obstet Gynecol Clin North Am 45:113-125
Sullivan-Pyke, Chantae S; Senapati, Suneeta; Mainigi, Monica A et al. (2017) In Vitro fertilization and adverse obstetric and perinatal outcomes. Semin Perinatol 41:345-353
Weinerman, Rachel; Feng, Rui; Ord, Teri S et al. (2016) Morphokinetic Evaluation of Embryo Development in a Mouse Model: Functional and Molecular Correlates. Biol Reprod 94:84
Luense, Lacey J; Wang, Xiaoshi; Schon, Samantha B et al. (2016) Comprehensive analysis of histone post-translational modifications in mouse and human male germ cells. Epigenetics Chromatin 9:24
Boots, Christina E; Hill, Micah J; Feinberg, Eve C et al. (2016) Methotrexate does not affect ovarian reserve or subsequent assisted reproductive technology outcomes. J Assist Reprod Genet 33:647-656
Boots, C E; Meister, M; Cooper, A R et al. (2016) Ovarian stimulation in the luteal phase: systematic review and meta-analysis. J Assist Reprod Genet 33:971-80

Showing the most recent 10 out of 50 publications